Učitavanje...
The limits of oral therapy in pulmonary arterial hypertension management
Pulmonary arterial hypertension (PAH) is a devastating disease in which remodeling of the small pulmonary arteries leads to a progressive increase in pulmonary vascular resistance and right-sided heart failure. Over the past decade, new treatments for PAH, such as the use of ERAs, PDE-5 inhibitors a...
Spremljeno u:
| Izdano u: | Ther Clin Risk Manag |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4664513/ https://ncbi.nlm.nih.gov/pubmed/26648729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S49026 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|